CCR2 and pancreatic neoplasm: Furthermore, in a CCR2-deficient mouse model, inhibition of monocyte-derived macrophage recruitment is not sufficient to inhibit tumor progression while deletion of resident macrophages significantly reduces tumor progression, demonstrating the impact of resident macrophages in pancreatic cancer progression (92).